Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OBN Appoints CEO

This article was originally published in Scrip

Executive Summary

OBN, the membership organisation for the UK's emerging life sciences companies, has appointed John Harris CEO, replacing interim CEO Ross Sommerville. Harris is currently delivering business and export advice to UK trade and industry clients and assisting life science companies on growth strategies. Most recently, Harris was managing partner of Qube Associates and previously he was managing director of IPS Specials/Vertical Pharma Ltd., Key Organics Ltd. and Synerga Ltd.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC063912

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel